Drug Shortage Report for BEXSERO
| Report ID | 215839 |
| Drug Identification Number | 02417030 |
| Brand name | BEXSERO |
| Common or Proper name | Multicomponent Meningococcal B Vaccine (recombinant, adsorbed) |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OUTER MEMBRANE VESICLES RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN |
| Strength(s) | 25MCG 50MCG 50MCG 50MCG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10s |
| ATC code | J07AH |
| ATC description | BACTERIAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2024-01-10 |
| Estimated end date | 2024-02-16 |
| Actual end date | 2024-02-09 |
| Shortage status | Resolved |
| Updated date | 2024-02-10 |
| Company comments | Supply available for public programs. Supply unavailable in the private market. Available in packs of 1. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-02-10 | English | Compare |
| v5 | 2024-02-09 | French | Compare |
| v4 | 2024-02-09 | English | Compare |
| v3 | 2024-01-12 | French | Compare |
| v2 | 2024-01-12 | English | Compare |
| v1 | 2024-01-12 | English | Compare |
Showing 1 to 6 of 6